This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chinese Academy of Sciences. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Yahui Zhang: Innovator in Neurodegenerative Disease Treatment
Introduction
Yahui Zhang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating neurodegenerative diseases.
Latest Patents
Yahui Zhang holds 1 patent for his invention titled "Isoquinoline-1,3,4-trione compounds, the synthetic method and the use thereof." This invention relates to various substituted isoquinoline-1,3,4-trione compounds, their synthetic methods, and their application in treating neurodegenerative diseases. Specifically, these compounds are designed to serve as medicines for conditions such as Alzheimer's disease, apoplexy, and brain ischemic injuries.
Career Highlights
Yahui Zhang is affiliated with the Chinese Academy of Sciences, where he conducts research and development in the field of medicinal chemistry. His work focuses on innovative solutions for complex health issues, particularly those affecting the brain.
Collaborations
Yahui Zhang has collaborated with notable colleagues, including Fajun Nan and Jia Tao Li, to advance research in his field. Their combined expertise contributes to the development of effective treatments for neurodegenerative diseases.
Conclusion
Yahui Zhang's innovative work in developing isoquinoline-1,3,4-trione compounds highlights his commitment to addressing critical health challenges. His contributions are paving the way for new therapeutic options in the treatment of neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile